Chief Strategy Officer Ryan Bond stated, "This milestone ensures we reach the study's conclusion, potentially unlocking broad ...

The trial aims to validate Nociscan’s ability to improve surgical outcomes for chronic low back pain patients. Enrolling 300 patients across multiple sites, it builds on peer-reviewed data ...

Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE ...

Renowned spine specialist, Dr. Sigurd Berven, will present Aclarion's flagship platform, NOCISCAN, highlighting its innovative, evidence-supported capabilities. “Aclarion is pleased to have ...

Aclarion (ACON) has secured full funding for its pivotal CLARITY trial which is designed to demonstrate Nociscan’s clinical and economic value ...

On January 31, Aclarion announced its participation in the Selby Spine Conference, where Dr. Sigurd Berven presented NOCISCAN ...

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed ...